Product Information
Name:R428
Synonyms:
- BGB324 Bemcentinib
Brand:Biosynth
Description:R428 is a small-molecule drug that is capable of inhibiting the BCR-ABL kinase and blocking the progression of chronic myelogenous leukemia. It has been shown to be effective in both in vitro and in vivo studies, with reduced toxicity compared to other treatments. R428 has been shown to inhibit proliferation of breast cancer cells in vitro and reduce the size of solid tumours in mice. This drug also inhibits epithelial mesenchymal transition (EMT) from epithelial cells to mesenchymal cells, which may be a potential mechanism for its anticancer activity.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:506.64 g/mol
Formula:C30H34N8
Purity:Min. 95%
Technical inquiry about: R428
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.